| (JPY) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 30.15B | — |
| Operating expense | — | — |
| Net income | 8.44B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 4521.T returned +8.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +1.4% |
| 1 year | +8.3% |
| 5 years | -1.1% |
| 10 years | -3.6% |
| All-time high | ¥11,460 (Aug 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ¥1,000 in 4521.T would be worth today ›Yes. Kaken Pharmaceutical Co., Ltd. paid 2 dividends over the past 12 months. The most recent was ¥95 per share on Mar 30, 2026. The dividend yield is 4.77%.
Kaken Pharmaceutical Co., Ltd. is part of the Healthcare sector.
Kaken Pharmaceutical Co., Ltd. has a market cap of 150.91B JPY, based on the latest quote.
